Table 1.

Sociodemographic and Clinical Variables in 77 Participants

			Calf			Thigh
Variable	n	%	Mean	SD	P	Mean	SD	P
Race
Black	36	46.8	1.81	0.82	.10	3.94	1.50	.600
White	41	53.2	2.12	0.80		4.11	1.39
Diagnosis
Schizophrenia/schizoaffective disorder	27	35.1	1.82	0.79	.20	3.60	1.21	.060*
Othera	50	64.9	2.06	0.83		4.26	1.51
Antipsychotic
Group 1b	10	13.0	1.93	1.16	.75	3.45	1.51	.150
Group 2c	40	51.9	1.92	0.77		3.92	1.33
Off antipsychotics	27	35.1	2.07	0.77		4.41	1.51
Metabolic syndrome
Yes	36	46.8	1.98	0.83	.99	4.17	1.62	.430
No	41	53.2	1.97	0.81		3.91	1.27
On statin
Yes	20	26.0	2.11	1.13	.49	4.02	1.85	.980
No	57	74.0	1.93	0.68		4.03	1.28
Smoking status
Yes	37	48.1	1.78	0.71	.05**	3.78	1.33	.140
No	40	51.9	2.15	0.88		4.26	1.51

^aPosttraumatic stress disorder (PTSD): n = 14, PTSD/anxiety: n = 2, PTSD/depression: n = 12, PTSD/schizophrenia: n = 2, bipolar disorder: n = 3, depression: n = 16, psychosis not otherwise specified: n = 1.

^bMedications with lower risk for weight gain: typical antipsychotics, ziprasidone, and aripiprazole. Typical antipsychotics were included in this group because of the small sample size.

^cMedications with higher risk for weight gain: olanzapine, quetiapine, and risperidone.

^*Subjects with schizophrenia had reduced thigh compliance at a trend level (P = .060) compared to subjects with other diagnoses.

^**Calf compliance was significantly reduced in smokers compared to nonsmokers.